Cite

    Bossuyt, P., Pouillon, L., Claeys, S., D'Haens, S., Hoefkens, E., Strubbe, B., Marichal, D., & Peeters, H. (2022). ultra-proactive Therapeutic Drug Monitoring of Infliximab Based on Point of Care Testing in Inflammatory Bowel Disease: Results of a Pragmatic Trial. Journal of Crohn's and colitis, 16, 199–206. http://access.bl.uk/ark:/81055/vdc_100151261218.0x00000b